title: Comparative Superiority of ACE Inhibitors Over Angiotensin Receptor Blockers for People With CKD: Does It Matter?
authors.affiliation: University of Ioannina, Ioannina, Greece. Electronic address: dmavridi@cc.uoi.gr.
authors.forename: Dimitris
authors.initials: D
authors.lastname: Mavridis
authors.affiliation: University of Otago, Christchurch, New Zealand.
authors.forename: Suetonia C
authors.initials: SC
authors.lastname: Palmer
authors.affiliation: The University of Sydney, Sydney, Australia; Diaverum, Lund, Sweden; University of Bari, Bari, Italy; The Children's Hospital at Westmead, Westmead, Australia.
authors.forename: Giovanni F M
authors.initials: GF
authors.lastname: Strippoli
mesh_terms: D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D057911:Angiotensin Receptor Antagonists / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D051436:Renal Insufficiency, Chronic / Q000188:drug therapy
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents